Timothy S. Luongo

Timothy S. Luongo

Auto-generated profile, based on publicly available information

Timothy S. Luongo

Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2015 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MKMohsin Khan
Mohsin Khan
ENEmily Nickoloff
Emily Nickoloff
TATatiana Abramova
Tatiana Abramova
JJJennifer Johnson
Jennifer Johnson
SVSuresh Verma
Suresh Verma
Raj KishoreRaj Kishore
Raj Kishore
Rationale:: Embryonic stem cells (ESCs) hold great promise for cardiac regeneration but are susceptible to various concerns. Recently, salutary effects of stem cells have been connected to exosome secretion. ESCs have the ability to produce exosomes, however, their effect in the context of the heart is unknown. Objective:: Determine the effect of ESC-derived exosome for the repair of ischemic myocardium and whether c-kit + cardiac progenitor cells (CPCs) function can be enhanced with ESC exosomes. Methods and Results:: This study demonstrates that mouse ESC-derived exosomes (mES Ex) possess ability to augment function in infarcted hearts. mES Ex enhanced neovascularization, cardiomyocyte survival, and reduced fibrosis post infarction consistent with resurgence of cardiac proliferative response. Importantly, mES Ex augmented CPC survival, proliferation, and cardiac commitment concurrent with increased c-kit + CPCs in vivo 8 weeks after in vivo transfer along with formation of bonafide new cardiomyocytes in the ischemic heart. miRNA array revealed significant enrichment of miR290-295 cluster and particularly miR-294 in ESC exosomes. The underlying basis for the beneficial effect of mES Ex was tied to delivery of ESC specific miR-294 to CPCs promoting increased survival, cell cycle progression, and proliferation. Conclusions:: mES Ex provide a novel cell–free system that uses the immense regenerative power of ES cells while avoiding the risks associated with direct ES or ES-derived cell transplantation and risk of teratomas. ESC exosomes possess cardiac regeneration ability and modulate both cardiomyocyte and CPC-based repair programs in the heart.

1 July 2015 in Cell Reports
Verified
Journal Article
Open access
TLTimothy S. Luongo
Timothy S. Luongo
JLJonathan P. Lambert
Jonathan P. Lambert
AYAncai Yuan
Ancai Yuan
XZXueqian Zhang
Xueqian Zhang
PGPolina Gross
Polina Gross
JEJohn W. Elrod
John W. Elrod
Cardiac contractility is mediated by a variable flux in intracellular calcium (Ca(2+)), thought to be integrated into mitochondria via the mitochondrial calcium uniporter (MCU) channel to match energetic demand. Here, we examine a conditional, cardiomyocyte-specific, mutant mouse lacking Mcu, the pore-forming subunit of the MCU channel, in adulthood. Mcu(-/-) mice display no overt baseline phenotype and are protected against mCa(2+) overload in an in vivo myocardial ischemia-reperfusion injury model by preventing the activation of the mitochondrial permeability transition pore, decreasing infarct size, and preserving cardiac function. In addition, we find that Mcu(-/-) mice lack contractile responsiveness to acute β-adrenergic receptor stimulation and in parallel are unable to activate mitochondrial dehydrogenases and display reduced bioenergetic reserve capacity. These results support the hypothesis that MCU may be dispensable for homeostatic cardiac function but required to modulate Ca(2+)-dependent metabolism during acute stress.

1 August 2013 in Immunity
Verified
Journal Article
Closed access
TZTongqing Zhou
Tongqing Zhou
JZJiang Zhu
Jiang Zhu
XWXueling Wu
Xueling Wu
SMStephanie Anne Moquin
Stephanie Anne Moquin
BZBaoshan Zhang
Baoshan Zhang
PKPeter D. Kwong
Peter D. Kwong

26 April 2017 in Nature
Verified
Journal Article
Closed access
PDF file
TLTimothy S. Luongo
Timothy S. Luongo
JLJonathan P. Lambert
Jonathan P. Lambert
PGPolina Gross
Polina Gross
MNMary Nwokedi
Mary Nwokedi
ALAlyssa A. Lombardi
Alyssa A. Lombardi
JEJohn W. Elrod
John W. Elrod

1 June 2015 in Cell
Verified
Journal Article
Closed access
TZTongqing Zhou
Tongqing Zhou
RLRebecca M. Lynch
Rebecca M. Lynch
LCLei Chen
Lei Chen
PAPriyamvada Acharya
Priyamvada Acharya
XWXueling Wu
Xueling Wu
PKPeter Kwong
Peter Kwong

29 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
PJPooja Jadiya
Pooja Jadiya
DKDevin W. Kolmetzky
Devin W. Kolmetzky
Dhanendra TomarDhanendra Tomar
Dhanendra Tomar
AMAntonio Di Meco
Antonio Di Meco
ALAlyssa A. Lombardi
Alyssa A. Lombardi
JEJohn W. Elrod
John W. Elrod
Impairments in neuronal intracellular calcium (iCa2+) handling may contribute to Alzheimer’s disease (AD) development. Metabolic dysfunction and progressive neuronal loss are associated with AD progression, and mitochondrial calcium (mCa2+) signaling is a key regulator of both of these processes. Here, we report remodeling of the mCa2+ exchange machinery in the prefrontal cortex of individuals with AD. In the 3xTg-AD mouse model impaired mCa2+ efflux capacity precedes neuropathology. Neuronal deletion of the mitochondrial Na+/Ca2+ exchanger (NCLX, Slc8b1 gene) accelerated memory decline and increased amyloidosis and tau pathology. Further, genetic rescue of neuronal NCLX in 3xTg-AD mice is sufficient to impede AD-associated pathology and memory loss. We show that mCa2+ overload contributes to AD progression by promoting superoxide generation, metabolic dysfunction and neuronal cell death. These results provide a link between the calcium dysregulation and metabolic dysfunction hypotheses of AD and suggest mCa2+ exchange as potential therapeutic target in AD.